IN2014DN06617A - - Google Patents
Info
- Publication number
- IN2014DN06617A IN2014DN06617A IN6617DEN2014A IN2014DN06617A IN 2014DN06617 A IN2014DN06617 A IN 2014DN06617A IN 6617DEN2014 A IN6617DEN2014 A IN 6617DEN2014A IN 2014DN06617 A IN2014DN06617 A IN 2014DN06617A
- Authority
- IN
- India
- Prior art keywords
- methods
- administration
- making
- same
- calcium
- Prior art date
Links
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361798689P | 2013-03-15 | 2013-03-15 | |
| PCT/US2014/029941 WO2014145219A1 (en) | 2013-03-15 | 2014-03-15 | Orally administrable compositions comprising calcium |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN06617A true IN2014DN06617A (enrdf_load_stackoverflow) | 2015-05-22 |
Family
ID=51537910
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN6617DEN2014 IN2014DN06617A (enrdf_load_stackoverflow) | 2013-03-15 | 2014-03-15 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US10675246B2 (enrdf_load_stackoverflow) |
| EP (1) | EP2968176B1 (enrdf_load_stackoverflow) |
| ES (1) | ES2749752T3 (enrdf_load_stackoverflow) |
| IN (1) | IN2014DN06617A (enrdf_load_stackoverflow) |
| WO (1) | WO2014145219A1 (enrdf_load_stackoverflow) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2968176B1 (en) * | 2013-03-15 | 2019-08-21 | Cerolife LLC | Orally administrable compositions comprising calcium |
| KR101683635B1 (ko) * | 2014-12-29 | 2016-12-09 | 가천대학교 산학협력단 | 락테이트 금속염을 포함하는 암 치료용 약학 조성물 |
| KR20180062063A (ko) * | 2016-11-30 | 2018-06-08 | (주) 메티메디제약 | 서방형 항암용 약학 조성물 |
| CN110368369B (zh) * | 2019-08-30 | 2021-11-05 | 广州新济药业科技有限公司 | 钙补充剂及其制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL115241A (en) | 1994-09-26 | 2000-08-31 | American Cyanamid Co | Calcium dietary supplement |
| EP1591143A1 (en) | 2004-04-26 | 2005-11-02 | Schaper & Brümmer Gmbh & Co. Kg | Composition comprising a combination of Calcium, Cimicifugae racemosae rhizoma and vitamin D and its use as a pharmaceutical in conditions or disorders associated with or resulting from calcium deficiency or as a nutritional supplement |
| US20070128272A1 (en) * | 2005-12-07 | 2007-06-07 | Zerbe Horst G | Multi-vitamin and mineral supplement |
| US20080166423A1 (en) * | 2007-01-06 | 2008-07-10 | Renjit Sundharadas | Combination Medication for Treating the Effects of Stomach Acid Reduction Medication on Bone Integrity |
| WO2009140341A2 (en) | 2008-05-13 | 2009-11-19 | Dr. Reddy's Laboratories Ltd. | Atorvastatin compositions |
| US8865213B2 (en) * | 2009-12-30 | 2014-10-21 | Usv Limited | Modified release pharmaceutical compositions |
| US20120244218A1 (en) * | 2011-03-25 | 2012-09-27 | Durkee Shane E | Calcium supplement |
| EP2968176B1 (en) * | 2013-03-15 | 2019-08-21 | Cerolife LLC | Orally administrable compositions comprising calcium |
-
2014
- 2014-03-15 EP EP14764664.0A patent/EP2968176B1/en active Active
- 2014-03-15 ES ES14764664T patent/ES2749752T3/es active Active
- 2014-03-15 US US14/777,287 patent/US10675246B2/en active Active
- 2014-03-15 IN IN6617DEN2014 patent/IN2014DN06617A/en unknown
- 2014-03-15 WO PCT/US2014/029941 patent/WO2014145219A1/en active Application Filing
-
2020
- 2020-06-03 US US16/892,157 patent/US20200297640A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2968176A1 (en) | 2016-01-20 |
| EP2968176B1 (en) | 2019-08-21 |
| ES2749752T3 (es) | 2020-03-23 |
| US10675246B2 (en) | 2020-06-09 |
| WO2014145219A1 (en) | 2014-09-18 |
| EP2968176A4 (en) | 2016-11-23 |
| US20200297640A1 (en) | 2020-09-24 |
| US20160022586A1 (en) | 2016-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GEP20217239B (en) | Pharmaceutical composition | |
| MX2020005181A (es) | Derivados de aminopiridina como inhibidores de cinasas de la familia de tyro3, axl y mer (tam). | |
| MX2015010921A (es) | Compuestos de carbazol utiles como inhibidores de bromodominio. | |
| MX365614B (es) | Composiciones utiles para tratar trastornos relacionados con kit. | |
| SG11201509136YA (en) | Cenicriviroc compositions and methods of making and using the same | |
| MX2020001756A (es) | Compuestos deuterados del inhibidor vmat y el uso de dichos compuestos. | |
| TN2015000519A1 (en) | Small molecule inhibitors of fibrosis | |
| MX2020004205A (es) | Composiciones antibioticas de ceftolozano. | |
| PL3560558T3 (pl) | Kompozycje nawozów oraz sposoby ich wytwarzania i stosowania | |
| MX2015011837A (es) | Co-cristale de pirimetanil y tetracarboximida de ditiina seleccionada. | |
| GEP20217240B (en) | Pharmaceutical composition | |
| EP3117827A4 (en) | Composition for vagina and use of the composition | |
| IN2013MU03641A (enrdf_load_stackoverflow) | ||
| PH12016501686A1 (en) | Pharmaceutical compositions of sitagliptin | |
| PH12016500495A1 (en) | Compositions for the treatment of hypertension and/or fibrosis | |
| PH12016500497A1 (en) | Compositions for the treatment of hypertension and/or fibrosis | |
| MX2015016603A (es) | Composiciones de corticosteroides. | |
| IN2014DN06617A (enrdf_load_stackoverflow) | ||
| GEP20217236B (en) | Composition comprising pentose and polyphenolic compound | |
| MY167350A (en) | Fat-and-oil composition and chocolate | |
| EP2994147A4 (en) | Compositions and methods for the treatment of tinnitus | |
| IN2013CH02437A (enrdf_load_stackoverflow) | ||
| IN2014CH00686A (enrdf_load_stackoverflow) | ||
| AU363054S (en) | Spigot | |
| MY180947A (en) | Ceftolozane antibiotic compositions |